AngelaJJohnsonMD

PubMed

• Dinaciclib is a novel cyclin dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia.
  Flynn, J.,Jones, J.,Johnson, A. J.,Andritsos, L.,Maddocks, K.,Jaglowski, S.,Hessler, J.,Grever, M. R.,Ellie, I.,Zhou, H.,Zhu, Y.,Zhang, D.,Small, K.,Bannerji, R.,Byrd,...> ;Leukemia. 2015 Feb 25
• miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.
  Guinn, D.,Ruppert, A. S.,Maddocks, K.,Jaglowski, S.,Gordon, A.,Lin, T. S.,Larson, R.,Marcucci, G.,Hertlein, E.,Woyach, J.,Johnson, A. J.,Byrd, J. C.> ;Leukemia. 2014 Dec 10
• Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response.
  Pierceall, W. E.,Warner, S. L.,Lena, R. J.,Doykan, C.,Blake, N.,Elashoff, M.,Von Hoff, D.,Bearss, D. J.,Cardone, M. H.,Andritsos, L.,Byrd, J. C.,Lanasa, M. C.,Grever, ...> ;Leukemia. 2014 Jul 06
• Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center.
  Stephens, D. M.,Ruppert, A. S.,Jones, J. A.,Woyach, J.,Maddocks, K.,Jaglowski, S. M.,Andritsos, L. A.,Flynn, J. M.,Grever, M. R.,Lozanski, G.,Johnson, A. J.,Muthusamy,...> ;Leukemia. 2014 Jan 24
• Serum amyloid A concentration in healthy periparturient mares and mares with ascending placentitis.
  Coutinho da Silva, M. A.,Canisso, I. F.,Macpherson, M. L.,Johnson, A. E.,Divers, T. J.> ;Equine Vet. J.. 2013 Sep
• Promoter Polymorphisms in ACE (Angiotensin I-converting Enzyme) Associated with Clinical Outcomes in Hypertension
  A D Johnson, P Binkley, C J Pepine> ;Wiley. 2008 Oct 24
• Join now to see all